Goldman Sachs Group Inc Kinnate Biopharma Inc. Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$2.24 - $2.66 $208,624 - $247,741	-93,136 Reduced 59.62%	63,090 $167,000
Q4 2023 Feb 13, 2024	BUY	$1.07 - $2.5 $82,662 - $193,137	77,255 Added 97.83%	156,226 $370,000
Q3 2023 May 14, 2024	SELL	$1.38 - $3.31 $106,611 - $255,714	-77,255 Reduced 49.45%	78,971 $110,000
Q3 2023 Nov 14, 2023	SELL	$1.38 - $3.31 $110,446 - $264,912	-80,034 Reduced 50.33%	78,971 $110,000
Q2 2023 May 14, 2024	SELL	$2.33 - $6.84 $140,992 - $413,902	-60,512 Reduced 27.57%	159,005 $481,000
Q2 2023 Aug 14, 2023	SELL	$2.33 - $6.84 $140,992 - $413,902	-60,512 Reduced 27.57%	159,005 $481,000
Q1 2023 May 14, 2024	BUY	$3.46 - $7.98 $510,277 - $1.18 Million	147,479 Added 204.72%	219,517 $1.37 Million
Q1 2023 May 11, 2023	BUY	$3.46 - $7.98 $510,277 - $1.18 Million	147,479 Added 204.72%	219,517 $1.37 Million
Q4 2022 May 14, 2024	SELL	$5.26 - $12.19 $671,965 - $1.56 Million	-127,750 Reduced 63.94%	72,038 $439,000
Q4 2022 Feb 13, 2023	SELL	$5.26 - $12.19 $671,965 - $1.56 Million	-127,750 Reduced 63.94%	72,038 $439,000
Q3 2022 May 14, 2024	SELL	$9.86 - $15.76 $110,136 - $176,039	-11,170 Reduced 5.29%	199,788 $2.39 Million
Q3 2022 Nov 10, 2022	SELL	$9.86 - $15.76 $110,136 - $176,039	-11,170 Reduced 5.29%	199,788 $2.39 Million
Q2 2022 May 14, 2024	BUY	$7.43 - $13.0 $406,658 - $711,516	54,732 Added 35.03%	210,958 $2.66 Million
Q2 2022 Aug 15, 2022	BUY	$7.43 - $13.0 $1.06 Million - $1.86 Million	142,804 Added 209.53%	210,958 $2.66 Million
Q1 2022 May 16, 2022	BUY	$7.73 - $17.99 $85,702 - $199,455	11,087 Added 19.43%	68,154 $767,000
Q4 2021 Feb 14, 2022	SELL	$16.5 - $25.48 $618,651 - $955,347	-37,494 Reduced 39.65%	57,067 $1.01 Million
Q3 2021 Nov 10, 2021	BUY	$17.81 - $24.87 $1.68 Million - $2.35 Million	94,561 New	94,561 $2.18 Million

Others Institutions Holding KNTE

# of Institutions

Shares Held

292K

Call Options Held

Put Options Held

Foresite Capital Opportunity Management V, LLC Larkspur, CA

292K
Shares

$0
10.46% of portfolio
Wipfli Financial Advisors Llc,

109
Shares

$0
0.0% of portfolio

View Full List

About Kinnate Biopharma Inc.

Ticker KNTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,145,600
Description
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...

More about KNTE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account